Inve US ▾
MPMPT

Medical Properties Trust (MPT) Q2 FY26 earnings call: guidance and Q&A

Earnings call· Jun 2026 (Q2 FY26)· Real Estate· Aug 10, 2026

Source: earnings call transcript

Executive summary

Medical Properties Trust Q2 FY26 — Debt Refinancing and Asset Sales Strengthen Balance Sheet

Medical Properties Trust executed a significant debt refinancing in Q2 FY26, pushing out substantial maturities and improving its liquidity profile. The company continues to see strong performance in its post-acute portfolio, while addressing challenges in behavioral health and specific U.S. operators. Strategic asset sales are validating portfolio values and providing capital for deleveraging, positioning MPT for a more balanced capital allocation strategy.

Highlights

5
  • Comprehensive refinancing transaction extends $2.4 billion of debt maturities to 2032, significantly reducing near-term maturities.

  • Post-acute operators delivered strong growth with EBITDARM increasing over $70 million year-over-year, including a 24% increase at Median and 13% at Ernest Health.

  • Recent asset sales and the Infracore IPO validated asset values, with one pending sale reflecting a 60% increase over original investment and a 34% IRR.

  • Consolidated ScionHealth and LifePoint leases into a single LifePoint master lease, enhancing credit profile.

  • UA UD bond covenant cushion expected to improve from 155-160% to almost 200% after Step 1, and up to 300% after Step 2.

Concerns

4
  • Behavioral Health remains a source of pressure, with U.K. market revenue impacted by NHS funding constraints, leading to 1.4x EBITDARM coverage.

  • HSA experienced mixed results due to MEDITECH EMR conversion issues and delayed Florida supplemental funding, causing lower cash collections and volume declines.

  • G&A expense was higher year-over-year primarily due to stock compensation and depreciation from the corporate headquarters building.

  • Impaired approximately $17 million in working capital loans primarily related to Steward replacement tenants in the Midwest.

Guidance & targets

CategoryTargetConfidence
Annualized cash rent
Over $1 billion
high materiality
High

Segment performance

SegmentRevenueYoYQoQMargin
General Acute
Comprises the majority of the portfolio; performance trends remain broadly stable.
EBITDARM coverage: 2.8x
————
Post-Acute
Delivered strong performance, with EBITDARM increasing over $70 million year-over-year.
EBITDARM coverage: 2.4x
————
Behavioral Health
Coverage was down slightly due to discrete headwinds in the U.K. and U.S. markets.
EBITDARM coverage: 1.4x
————

Deals & partnerships

Infracore Swiss joint venture went public and listed on SIX Exchange.

MPT retains a significant ownership position and remains bullish on Switzerland.

LifePoint / ScionHealth Consolidated all ScionHealth general acute hospitals and LifePoint leases into one LifePoint master lease.

Scion transitioned certain MPT-owned acute hospitals to LifePoint.

Ernest Health Ernest Health's acquisition of Reunion Rehabilitation Hospital.

MPT is excited to see Ernest continue to grow with this acquisition.

Capital programs

Culver City Emergency Department project progressing

The emergency department project at Culver City is progressing and remains scheduled to open in the fourth quarter of 2027.

Risks & headwinds

Behavioral Health segment pressure Q2 FY26

EBITDARM coverage down slightly to 1.4x.

Mitigation:Management impressed with activity, confident in opportunities, encouraged by long-term investment potential.

U.K. NHS funding pressures Ongoing

Revenue impacted.

Mitigation:Priory taking proactive measures, implementing disciplined cost control, optimizing services.

HSA operational disruptions (EMR conversion, RCM transition, delayed Florida funding) Q2 FY26

Lower cash collections and volume declines in some markets; cash collections still lagging.

Mitigation:MEDITECH conversion largely behind them; RCM brought back in-house; expects to improve revenue cycle and operational efficiency; received significant Florida payments in August.

Impairment of working capital loans Q2 FY26

$17 million impaired.

Mitigation:Primarily related to Steward replacement tenants in the Midwest.

What to watch in Q3 FY26

HSA cash collections improvement

Next quarter
Current Still lagging (previously 82%, dipped from 78%)
Target Improved cash collections, approaching 90%+ range.

Why it matters

Critical for HSA's liquidity and MPT's rent collection, impacting FFO.

While cash collections are still lagging, HSA has received significant payments from the Florida supplemental funding program in August, enabling them to begin repayment of the working capital advances we made during the quarter. While trailing 12-month EBITDARM to cash rent coverage of 2x, we remain cautiously optimistic about the trajectory of HSA and we'll continue carefully monitoring their operations.

Find out whether MPT delivers this. Inve re-checks your case every morning.

Q&A highlights

Inquired if the balance of 2027 notes would be paid off using a new credit line and the associated rate.

Steve Hamner clarified that the repayment of 2027 notes (Step 2) would not solely rely on a credit line, but rather a combination of asset sales, existing liquidity, and additional secured debt opportunities.

“No. We have a number of options that we've always had including asset sales, including liquidity that we have and including additional secured debt opportunities.”

asked by Mike Mueller · answered by R. Hamner

2 min read 5 chapters

Detailed narrative

Debt Refinancing Strategy

MPT announced a two-step refinancing process to address $2.7 billion in 2026 and 2027 debt maturities, plus an additional $1.2 billion of longer-dated unsecured notes. Step 1 involves issuing $2.4 billion in secured notes to redeem EUR 500 million of 2026 notes and approximately $738 million (53%) of 2027 notes, while exchanging $1.2 billion of longer-dated notes at a discount, reducing gross debt by $123 million.

Step 2 will repay the remainder of the 2027 notes, establish a new multiyear bank revolver, and repay a $200 million term loan due June 2027, resulting in no debt maturities until June 2028.

Asset Valuation and Sales

The company highlighted that market values of its hospital assets exceed book values, affirmed by the Infracore IPO and recent transactions. A pending sale is expected to generate $172 million in after-debt cash proceeds, reflecting a 60% increase over original investment and a 34% IRR.

MPT is negotiating additional asset sales that could generate $200 million to $400 million more in cash proceeds, also at significant gains over original investments.

Operator Performance and Challenges

Post-acute operators, including Median (24% increase) and Ernest Health (13% increase), showed strong EBITDARM growth, contributing to a 2.4x coverage. General acute operators maintained 2.8x coverage. However, Behavioral Health coverage declined to 1.4x due to U.K. funding pressures and U.S. market headwinds. HSA faced disruptions from an EMR conversion and delayed Florida supplemental funding, impacting cash collections, though operational coverage was 2x.

Lease Consolidation and Rent Escalations

MPT consolidated all ScionHealth general acute hospitals and LifePoint leases into a single LifePoint master lease, maintaining cash rent levels. NOR began paying 50% contractual rent in June, increasing to 100% in mid-December, while HSA is currently paying 75% contractual rent, increasing to 100% in mid-September.

Liquidity and Leverage

Upon completion of the refinancings and asset sales, MPT expects to have up to $1.1 billion in liquidity. The UA UD bond covenant cushion is projected to improve significantly, from 155-160% to almost 200% after Step 1, and potentially up to 300% after Step 2, providing substantial flexibility for further deleveraging.

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.